default author photo

Xin Huang

Zhejiang University - Department of Hematology

China

Key Laboratory of Hematopoietic Malignancies

Zhejiang

China

SCHOLARLY PAPERS

2

DOWNLOADS

119

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

CAG Regimen for Refractory or Relapsed Adult T-Cell Acute Lymphoblastic Leukemia: A Retrospective, Multicenter, Cohort Study

Number of pages: 28 Posted: 21 Sep 2019
Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Government of the People's Republic of China - Changzheng Hospital, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Shulan (Hangzhou) Hospital, Government of the People's Republic of China - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Shaoxing Central Hospital, Peking University, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology and Zhejiang University - Department of Hematology
Downloads 73 (860,052)
Citation 1

Abstract:

Loading...

T-cell acute lymphoblastic leukemia; refractory or relapse; stem cell transplantation

2.

High PARP-1 Expression Predicts Poor Survival in Acute Myeloid Leukemia and PARP-1 Inhibitor and Saha-Bendamustine Hybrid Inhibitor Combination Treatment Synergistically Enhances Anti-Tumor Effects

, EBioMedicine, Volume 38, December 2018, Pages 47-56, https://doi.org/10.1016/j.ebiom.2018.11.025
Number of pages: 47 Posted: 24 Sep 2018
Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Hangzhou First People’s Hospital, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - College of Pharmaceutical Sciences and Zhejiang University - Department of Hematology
Downloads 46 (1,133,231)

Abstract:

Loading...

PARP-1, Acute myeloid leukemia, PARP inhibitor, SAHAbendamustine hybrid